Invention Grant
- Patent Title: CD3 antigen binding fragment and application thereof
-
Application No.: US17432892Application Date: 2019-02-22
-
Publication No.: US11639388B2Publication Date: 2023-05-02
- Inventor: Jing Zhang , Lijuan Fang , Yongxiang Yan , Liang Zeng , Pengfei Zhou
- Applicant: Wuhan YZY Biopharma Co., Ltd.
- Applicant Address: CN Wuhan
- Assignee: Wuhan YZY Biopharma Co., Ltd.
- Current Assignee: Wuhan YZY Biopharma Co., Ltd.
- Current Assignee Address: CN Wuhan
- Agency: Sheppard Mullin Richter & Hampton LLP
- International Application: PCT/CN2019/075901 WO 20190222
- International Announcement: WO2020/168555 WO 20200827
- Main IPC: C07K16/28
- IPC: C07K16/28

Abstract:
Provided in the present application is a humanized and multifunctional CD3 antibody; a heavy chain variable region of the CD3 antibody comprised herein contains the amino acid sequence of any one of SEQ ID NOs: 1-3 or a variant sequence thereof; and a light chain variable region thereof contains the amino acid sequence of any one of SEQ ID NOs: 26-28 or a variant sequence thereof. Further provided in the present application is a multifunctional antibody comprising (a) a light chain-heavy chain pair that has specificity for tumor cells or microorganisms; and (b) a fusion peptide that comprises a single-chain variable fragment and an Fc fragment having a CH2 domain and/or a CH3 domain, the fusion peptide having specificity for immune cells. The antibodies provided in the present application have improved biological activity, thermal stability and/or acid resistance.
Information query